GO2PHARMACY COM INC
10QSB, EX-27, 2000-12-22
DAIRY PRODUCTS
Previous: GO2PHARMACY COM INC, 10QSB, 2000-12-22
Next: LUMENON INNOVATIVE LIGHTWAVE TECHNOLOGY INC, 424B3, 2000-12-22



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          MAR-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          64,320
<SECURITIES>                                         0
<RECEIVABLES>                                  734,219
<ALLOWANCES>                                   143,493
<INVENTORY>                                  1,668,821
<CURRENT-ASSETS>                             3,071,676
<PP&E>                                       1,487,137
<DEPRECIATION>                                 489,066
<TOTAL-ASSETS>                               5,195,429
<CURRENT-LIABILITIES>                        3,913,096
<BONDS>                                              0
                        1,500,000
                                          0
<COMMON>                                        30,000
<OTHER-SE>                                   (663,152)
<TOTAL-LIABILITY-AND-EQUITY>                 5,195,429
<SALES>                                      2,878,036
<TOTAL-REVENUES>                             2,878,036
<CGS>                                        1,751,898
<TOTAL-COSTS>                                1,751,898
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             130,608
<INCOME-PRETAX>                               (31,691)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (31,691)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (31,691)
<EPS-BASIC>                                      (.01)
<EPS-DILUTED>                                    (.01)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission